Literature DB >> 9781059

Comparison of conformation-sensitive gel electrophoresis and single-strand conformation polymorphism analysis for detection of mutations in the BRCA1 gene using optimized conformation analysis protocols.

A Markoff1, H Sormbroen, N Bogdanova, S Preisler-Adams, V Ganev, B Dworniczak, J Horst.   

Abstract

In order to develop a selective mutation screening strategy for BRCA1, one of the gene responsible for hereditary predisposition to breast cancer, we analysed by single-strand conformation polymorphism (SSCP) and conformation-sensitive gel electrophoresis (CSGE) a cohort of 20 Bulgarian breast cancer patients, prescreened for nonsense mutations by the protein truncation test. By assaying the complete coding sequence of the gene applying both methods, we were able to detect 12 sequence alterations: 11 nucleotide substitutions and one deletion. Two of the alterations are intronic polymorphisms, the rest are exon sequence variants. Of the 12 polymorphisms identified, 11 are described and one is new. All sequence changes were detected by CSGE and eight of them were also shown by SSCP analysis. There was no sequence alterations which could be detected by SSCP analysis only. We propose that because of the specificity of most sequence variants detected (nucleotide substitutions) and the comparatively high percentage of AT content of the BRCA1 gene (58.4%), CSGE turned out to be the more sensitive technique in our assay. This observation is in agreement with other accepted analysis strategies for BRCA1 and it may prove useful for mutation screening of AT-rich, multi-exon genes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9781059     DOI: 10.1038/sj.ejhg.5200171

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  4 in total

1.  Rapid detection of deletion, insertion, and substitution mutations via heteroduplex analysis using capillary- and microchip-based electrophoresis.

Authors:  H Tian; L C Brody; J P Landers
Journal:  Genome Res       Date:  2000-09       Impact factor: 9.043

2.  Alterations in p53, BRCA1, ATM, PIK3CA, and HER2 genes and their effect in modifying clinicopathological characteristics and overall survival of Bulgarian patients with breast cancer.

Authors:  Stefan S Bozhanov; Svetla G Angelova; Maria E Krasteva; Tsanko L Markov; Svetlana L Christova; Ivan G Gavrilov; Elena I Georgieva
Journal:  J Cancer Res Clin Oncol       Date:  2010-02-23       Impact factor: 4.553

3.  Niemann-Pick C variant detection by altered sphingolipid trafficking and correlation with mutations within a specific domain of NPC1.

Authors:  X Sun; D L Marks; W D Park; C L Wheatley; V Puri; J F O'Brien; D L Kraft; P A Lundquist; M C Patterson; R E Pagano; K Snow
Journal:  Am J Hum Genet       Date:  2001-05-09       Impact factor: 11.025

4.  Spectrum and frequencies of BRCA1/2 mutations in Bulgarian high risk breast cancer patients.

Authors:  Rumyana Ivanova Dodova; Atanaska Velichkova Mitkova; Daniela Rosenova Dacheva; Lina Basam Hadjo; Alexandrina Ivanova Vlahova; Margarita Stoyanova Taushanova -Hadjieva; Spartak Stoyanov Valev; Marija Mitko Caulevska; Stanislava Dimitrova Popova; Ivan Emilov Popov; Tihomir Iliichev Dikov; Theophil Angelov Sedloev; Atanas Stefanov Ionkov; Konstanta Velinova Timcheva; Svetlana Liubomirova Christova; Ivo Marinov Kremensky; Vanio Ivanov Mitev; Radka Petrova Kaneva
Journal:  BMC Cancer       Date:  2015-07-17       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.